Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

ACELLDream for Adipose CELL Derived Regenerative Endothelial Angiogenic Medicine (ACELLDREAM)

This study has been completed.
Unity Research 5241 UPS/CNRS
French Blood Establishment (Midi-Pyrénées)
Clinical Investigation Centre
Information provided by (Responsible Party):
University Hospital, Toulouse Identifier:
First received: March 31, 2010
Last updated: June 11, 2014
Last verified: June 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)